4
Changes in Ownership
Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-25-028230
Options or other derivatives
- Director returned 50,000 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Almenoff June Sherie · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-31 | Returned to the company : show line 1 in the form Stock Option (Right to Buy) | −50,000 | 0 | D |
Loading xslF345X05/ownership.xml…